Z17.4 - Combined receptor status
- Applicable to Combined receptor status
- The 2025 edition of ICD10-CM Z17.4 became effective on October 1, 2024.
- This is the American ICD10-CM version of Z17.4 - other international versions of ICD10 Z17.4 may differ.
- Z17.4 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Z17.4 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- Z17.4 - Combined receptor status
- Z17.4 - Combined receptor status
- Z17.41 - Hormone receptor positive
- Z17.410 - Hormone receptor positive with human epidermal growth factor receptor 2 positive status
- Z17.411 - Hormone receptor positive with human epidermal growth factor receptor 2 negative status
- Z17.42 - Hormone receptor negative
- Z17.420 - Hormone receptor negative with human epidermal growth factor receptor 2 positive status
- Z17.421 - Hormone receptor negative with human epidermal growth factor receptor 2 negative status
Code Notes:
- Assign a code from subcategory Z17.4- when only a combined receptor status is documented
Non-Billable/Non-Specific Code
The following codes above Z17.4 contain annotation back-references that may be applicable to Z17.4:
- Chapter: Z00-Z99 - Factors influencing health status and contact with health services
- Section: Z17 - Estrogen, and other hormones and factors receptor status
- Category: Z17 - Estrogen receptor status
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com